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Abstract
Purpose The optimal surgical approach for perforated diverticulitis with purulent or fecal peritonitis (Hinchey grade III or IV)
remains debated. In recent years, accumulating evidence comparing sigmoid resection with primary anastomosis (PA) with the
Hartmann’s procedure (HP) was presented. Therefore, the aim was to provide an updated and extensive synthesis of the available
evidence.
Methods A systematic search in Embase, MEDLINE, Cochrane, and Web of Science databases was performed. Studies com-
paring PA to HP for adult patients with Hinchey III or IV diverticulitis were included. Data on mortality, morbidity, stoma
reversal, and patient-reported and cost-related outcomes were extracted. Random effects models were used to pool data and
estimate odds ratios (ORs).
Results From a total of 1560 articles, four randomized controlled trials and ten observational studies were identified, reporting on
1066Hinchey III/IV patients. Based on trial outcomes, PAwas found to be favorable over HP in terms of stoma reversal rates (OR
2.62, 95% CI 1.29, 5.31) and reversal-related morbidity (OR 0.33, 95% CI 0.16, 0.69). No differences in mortality (OR 0.83,
95% CI 0.32, 2.19), morbidity (OR 0.99, 95% CI 0.65, 1.51), and reintervention rates (OR 0.90, 95% CI 0.39, 2.11) after the
index procedure were demonstrated. Data on patient-reported and cost-related outcomes were scarce, as well as outcomes in PA
patients with or without ileostomy construction and Hinchey IV patients.
Conclusion Although between-study heterogeneity needs to be taken into account, the present results indicate that primary
anastomosis seems to be the preferred option over Hartmann’s procedure in selected patients with Hinchey III or IV diverticulitis.
Keywords Perforated diverticulitis . Peritonitis . Hartmann’s procedure . Primary anastomosis
Introduction
Up to 35% of patients with acute diverticulitis present with
complicated disease, such as perforation with purulent or fecal
peritonitis (Hinchey III or IV) [1–4]. Treatment of perforated
diverticulitis with peritonitis generally requires emergency
surgical treatment [5]. However, the optimal surgical treat-
ment strategy remains a topic of debate.
Although the Hartmann’s procedure (HP) has been the
favored approach for most surgeons, outcomes of
sigmoidectomy with primary anastomosis (PA) have been
reported to be comparable to those of HP [6, 7]. Previous
studies have found PA to be associated with higher stoma
reversal rates and another important potential benefit of PA
is the option to avoid a defunctioning ileostomy in selected
cases [8–11]. Moreover, restoration of intestinal continuity
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after HP is reported to be associated with higher morbidity
and mortality rates [12, 13]. Hence, PA has the potential
benefit to decrease patient burden, lower associated
healthcare costs, and improve patient-reported outcomes
[14].
Particularly in the light of increased incidence and admis-
sion rates of perforated diverticulitis, a critical appraisal of
treatment strategies and their outcomes is an important step
towards consensus on its optimal surgical approach [15].
Therefore, the aim of this systematic review and meta-
analysis was to assess outcomes of HP and PA (with or with-
out ileostomy) for perforated diverticulitis with purulent or
fecal peritonitis.
Methods
The study was conducted following the MOOSE and
PRISMA guidelines [16, 17] and was registered in
PROSPERO (CRD42019135333). Approval of the institu-
tional review board and written consent were not required.
Study design
Case reports, review articles, meta-analyses, letters, abstracts,
or comments were excluded. Randomized controlled trials
(RCTs) and prospective or retrospective cohort studies were
included if they met the following criteria: reporting on (1)
patients ≥ 18 years of age with acute left-sided perforated di-
verticulitis with peritonitis (Hinchey III or IV) and (2) a com-
parison of HP and PA (with or without defunctioning
ileostomy). Exclusion criteria were (1) studies reporting on
Hinchey I or II diverticulitis, chronic diverticular complica-
tions (e.g. fistulae or obstruction), non-diverticular colorectal
disease, or elective surgery, in which outcomes could not be
assessed separately from Hinchey III and IV diverticulitis; (2)
non-comparative studies; and (3) non-English studies.
Systematic literature search
A biomedical information specialist performed a systematic
search in collaboration with one of the reviewers (DL). The
Embase, MEDLINE, Cochrane, and Web of Science data-
bases were searched on June 17, 2019. Publication date was
not limited and the initial search was not restricted by lan-
guage. Search syntaxes and results per database are given in
the Appendix. An additional search through reference lists
was performed. Two researchers (DL and PE) independently
reviewed the identified articles by title and abstract and, sub-
sequently, by full text using EndNote X9®. Differences in
article selection were discussed and articles were included or
excluded after consensus was reached between reviewers.
Data collection
Two researchers (DL and PE) extracted data, which were
checked by a third independent researcher (RB).
Discrepancies were discussed until consensus was reached.
In the case of uncertainties with regard to reported outcomes,
corresponding authors were contacted when possible. The fol-
lowing study details were collected: author, year, country/
countries, design, and length of follow-up, and—if applica-
ble—sample size, inclusion period, number of screened and
included patients, eligibility criteria, cross-overs, moment of
randomization, primary endpoint, and trial accrual. Extracted
baseline patient and operative characteristics were sex, age,
body mass index (BMI) , Amer i can Soc i e ty o f
Anesthesiologists (ASA) score, preoperative disease severity,
Hinchey grade, previous diverticulitis and abdominal surgery,
surgical expertise, time and duration of surgery, blood loss,
approach (open/laparoscopic), anastomotic configuration and
construction, drain placement, and intraoperative lavage.
Moreover, the following outcomes were collected: mortality,
morbidity, hospital stay, intensive care unit (ICU) stay,
(ongoing) sepsis, anastomotic leakage, intra-abdominal ab-
scess occurrence and drainage, malignancies, surgical site in-
fections (SSI), organ dysfunction, fascial dehiscence, stoma
reversal rates, and hernia rates. Additionally, data on patient-
reported outcomes and associated costs were extracted.
Risk of bias and quality assessment
Study quality was assessed independently by two researchers
(DL and PE) using the level of evidence [18], Newcastle-
Ottawa Scale (NOS), and methodological index for non-
randomized studies (MINORS) criteria [19, 20]. For RCTs,
the Cochrane Collaboration’s risk-of-bias tool was used [21].
Discrepancies in quality assessment outcomes were resolved
by discussion.
Data synthesis and statistical analysis
To calculate pooled odds ratios (ORs) with 95% CI, the
Mantel-Haenszel random effects model was used, which
takes between-study and within-study variance into ac-
count. For continuous variables, inverse variance-
weighted random effects models were used to calculate
mean differences (MD) with 95% CI. Statistical heteroge-
neity was evaluated by calculating Q statistics and I2. In
addition, risk differences (RDs), risk ratios (RRs), and
numbers needed to treat (NNTs) were calculated for out-
comes that were significantly different between treatment
groups. Analyses were performed using RevMan 5.3
(Cochrane Centre, Copenhagen, Denmark).
Int J Colorectal Dis
Results
Systematic literature search
Details of the study selection are provided in a
PRISMA flow diagram (Fig. 1). After duplicate remov-
al, 1560 of 2578 articles were further assessed.
Eventually, 14 articles were included after title and ab-
stract screening and full-text reading.
Study, patient, and operative characteristics
Study characteristics are given in Table 1. Overall, four
RCTs were included [22–25], as well as three prospective
[10, 11, 26] and seven retrospective observational studies
[27–33]. Overall, data on a total of 1274 patients were
available most of whom had Hinchey grade III/IV divertic-
ulitis (1066/1274, 83.7%). Data were available on 731 and
536 patients who underwent or were allocated to HP or PA,
respectively. Risk of bias assessment of the included RCTs
is shown in Supplemental Fig. 1. For the non-randomized
studies, the NOS and MINORS scores ranged between 6–9
and 13–18, respectively. An overview of patient baseline
characteristics is given in Table 2. Moreover, Supplemental
Tables 1 and 2 provide details on the reported operative
characteristics of index and reversal procedures. In
Supplemental Table 3, summarized results of a quantitative
analysis of baseline characteristics in the included obser-
vational studies are presented. As compared to HP, PA
patients were more likely to undergo surgery for Hinchey
III diverticulitis (OR 2.45, 95% CI 1.30, 4.63, p = 0.006)
and to have a lower mean age (MD − 4.84, 95% CI − 9.41,
Fig. 1 PRISMA flow diagram
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− 0.27, p = 0.04) and MPI score (MD − 3.58, 95% CI −
5.70, − 1.47, p = 0.0009).
Randomized controlled trials
Details of the four included RCTs are provided in
Supplemental Table 4. Overall, 204 HP and 180 PA patients
were analyzed. Reported inclusion and exclusion criteria var-
ied between trials, mainly in terms of exclusion criteria. The
only trial to report reasons for not screening patients for eligi-
bility and non-inclusion of screened patients was that by
Oberkofler and colleagues [23]. Overall, 53 patients were
not assessed for participation due to disagreement of the sur-
geon (40% HP, 30% PA with diverting ileostomy, 22% PA
without diverting ileostomy, 8% others). Moreover, the au-
thors reported that 21 patients were not included, because they
declined to participate (n = 7) or did not meet inclusion criteria
(n = 14). The Ladies trial [25] was the only study to be able to
assess differences between the included patients and a cohort
of 235 non-included but eligible patients, showing that in the
latter group a GI surgeon was less often present (68.7% vs.
88.5%, p < 0.001) and the median interval to surgery was
longer (13.5 h (6–43.8) vs. 8.8 (5.3–29.3), p = 0.02).
However, no difference in in-hospital mortality was found
for non-included (20/235, 8.5%) and included patients
(6/130 (4.6%), p = 0.21). Three of the four trials randomized
preoperatively, whereas in the Ladies trial patients were ran-
domized intraoperatively. All trials were terminated early due
to recruitment difficulties. Oberkofler et al. [23] reported sig-
nificant differences in relevant secondary endpoints to be an
additional argument for early discontinuation, although they
did not specify which endpoints. In total, 31.5% (384/1218) of
the overall calculated sample sizes was reached.
Index procedure: mortality
An overview of outcomes after the index procedure is given in
Tables 3 and 4. Eleven of the included studies reported on
mortality rates during follow-up for Hinchey III/IV patients.
As shown in Fig. 2a, no difference was found in the occur-
rence of short-term mortality in a quantitative analysis of
RCTs, with mortality occurring in 5% (9/180) of PA and
6.4% (13/204) of HP patients (OR 0.83 (95% CI 0.32,
2.19)). In addition, long-term mortality, defined as occurring
within the trials’ full study period, showed no difference be-
tween PA and HP (9/179 (5%) vs. 17/204 (8.3%), OR 0.61,
95% CI 0.25, 1.47) as shown in Fig. 2b. A separate quantita-
tive analysis of data from observational studies (n = 7) showed
a significant difference in overall mortality in favor of PA (18/
146 (12.3%)) as compared to HP (68/233 (29.2%)) with an
OR of 0.39 (95% CI 0.18, 0.85) (Fig. 2c).
Index procedure: morbidity
The overall morbidity rates in RCTs are provided in Fig. 3a,
which shows no difference between both procedures with an
OR of 0.99 (95% CI 0.65, 1.51; PA 91/180 (50.6%) vs. HP
101/204 (49.5%)). An additional analysis of short-term seri-
ous complications (Clavien-Dindo grade > IIIa) within the
RCTs (Fig. 3b) also did not show a difference between PA
and HP (30/145 (20.7%) vs. 31/148 (20.9%), OR 0.95, 95%
CI 0.53, 1.72). Additionally, morbidity could be assessed in
four observational studies (Fig. 3c), which showed an OR of
1.01 (95% CI 0.21, 4.96; PA 28/62 (45.2%) vs. HP 85/176
(48.3%)).
Reintervention rates after the index procedure, including
surgical reinterventions and abscess drainage, were assessed
within the RCTs (Supplemental Fig. 2a) and no differences
were demonstrated between both procedures (PA 11/148
(7.4%) vs. HP 13/174 (7.5%); OR 0.90, 95% CI 0.39, 2.11).
A separate analysis of reoperation rates within these trial data
also showed no differences (Supplemental Fig. 2b). From ob-
servational studies (n = 3), reintervention rates were 6.7%
(6/90) and 16.3% (16/98) for PA and HP, respectively (OR
0.52, 95% CI 0.19, 1.46; see Supplemental Fig. 2c).
Nine studies provided anastomotic leakage rates after the
index procedure, which showed the occurrence of 14 leakages
in 226 PA patients (6.2%) and 3 leakages in 298 HP patients
(1%). In the latter group, one patient had a rectal stump leak-
age [22], whereas two other patients were stated to have anas-
tomotic leakage due to the presence of fistulas in the study by
Regenet et al. [10]. Forest plots of surgical site infections,
postoperative (ongoing) sepsis, and fascial dehiscence did
not show significant differences between both treatment
groups in experimental and observational studies
(Supplemental Fig. 3a, b, c, d, e, and f).
Stoma- and reversal-related outcomes
An overview of outcomes after the reversal procedure is given
in Supplemental Tables 6a and b. In Fig. 4a, reversal rates of
constructed stomas were assessed within the included trials,
showing a significant difference in favor of PA (118/147
(80.3%)) over HP (126/203 (62.1%); OR 2.62, 95% CI 1.29,
5.31), with an associated NNT of 5 (Supplemental Table 5).
From the assessment of the number of stoma-free patients
during trial follow-up, as provided in Fig. 4b, PA also showed
favorable outcomes over HP (PA 150/179 (83.8%) vs. HP
127/204 (62.3%); OR 3.21, 95% CI 1.42, 7.26; NNT 5).
Reversal rates of the studies that could not be included are
shown in Supplemental Table 6a.
Reasons for non-reversal were mentioned in the trial of
Oberkofler et al. [23], including patient’s choice and the sur-
geon’s risk assessment, but related percentages were not pre-
sented. Bridoux and colleagues found that reasons for not
Int J Colorectal Dis
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undergoing stoma reversal in the HP group were the patient’s
choice (n = 8/17) or if a patient was deemed unfit for surgery
(n = 9/17) [24]. The latter was also the case in 2 of 16 PA
patients, whereas the other 14 patients had no stoma construct-
ed. In the Ladies trial, reasons were the surgeon’s disapproval
(HP: n = 3/21, PA: n = 1/8), patient’s preferences (HP: n = 2/
21, PA; n = 1/8), or mortality before reversal (HP: 7/21, PA:
n = 4/8), or they were unknown (HP: n = 8/21, PA: n = 2/8)
[25].
One case of reversal-related mortality was reported within
the included studies, which was caused by mesenteric ische-
mia after atrial fibrillation [24]. Postoperative morbidity relat-
ed to the reversal procedure was assessed in four studies (Fig.
4c), being the four included trials, which showed a significant
difference in favor of PA (PA 14/118 (11.9%) vs. HP 34/126
(27%); OR 0.33, 95% CI 0.16, 0.69; NNT 7). This difference
was not found when serious complications were assessed in
two of the four trials that reported these figures, as shown in
Fig. 4d (PA 1/58 (1.7%) vs. HP 6/48 (12.5%); OR 0.18, 95%
CI 0.03, 1.15).
Outcomes of index and reversal procedure combined
An analysis of the short-term mortality of the index and rever-
sal procedures combined (Supplemental Fig. 4a) did not show
a significant difference, with an OR of 0.76 (PA 9/179 (5%)
vs. HP 14/204 (6.9%); 95% CI 0.29, 1.96). Additionally,
short-term morbidity was assessed for the combined proce-
dures (Supplemental Fig. 4b), which showed no difference
between both treatment groups (PA 88/179 (49.2%) vs. HP
120/204 (58.8%); OR 0.64, 95% CI 0.37, 1.13). The occur-
rence of anastomotic leakage after both the index and reversal
procedure combinedwas assessed in the four RCTs, which did
not show a difference between PA and HP (respectively, 6/179
(3.4%) vs. 6/204 (2.9%); OR 1.04, 95% CI 0.30, 3.52; see
Supplemental Fig. 4c).
Outcomes in Hinchey IV patients
Four studies specifically reported on outcomes of Hinchey IV
diverticulitis. Binda et al. [22] found the type of peritonitis
(purulent or fecal) to be significantly related to morbidity
(28/75 (37.3%) vs. 10/15 (66.7%), p = 0.047) and mortality
(3/75 (4%) vs. 4/15 (26.7%), p = 0.014) in multivariate anal-
ysis. Outcomes of Hinchey III and IV patients were assessed
separately in the Ladies trial [25], showing the 12-month sto-
ma-free survival after PA to be significantly better for both
Hinchey grades (III: hazard ratio 2.35, 95% CI 1.49, 3.71;
IV: hazard ratio 4.15, 95% CI 1.71, 10.1). Within the
Hinchey IV group, no significant differences in short-term
postoperative outcomes after the index procedure were dem-
onstrated between HP and PA (mortality 2/20 (10%) vs. 3/18
(16.7%); overall morbidity 12/20 (60%) vs. 8/18 (44.4%), p =
0.52). Also, no differences in short-term post-reversal out-
comes were found, with no mortality in both treatment groups
and an overall morbidity of 30% in the HP group and 0% in
the PA group (p = 0.21). Trenti and colleagues [11] performed
a logistic regression analysis with Hinchey grade (IV vs. III),
Peritonitis Severity Score (≤ 9), ASA (III–IV vs. I–II), and
treatment (HP vs. PA), but did not find Hinchey grade to be
independently associated with postoperative mortality and
morbidity, wound infection, or reoperation. Moreover, in the
study by Vermeulen et al. [30], multivariate analyses adjusting
for treatment, age, ASA, MPI, surgeon’s experience, and
Hinchey grades showed Hinchey grade IV disease to be inde-
pendently associated with the outcome as compared to the
reference group of Hinchey I patients (postoperative mortali-
ty: OR 3.9, 95% CI 1.0, 13.8, p = 0.03; reinterventions: OR
3.9, 95% CI 1.3, 12.7, p = 0.02).
Outcomes of primary anastomosis with or without
ileostomy
Bridoux et al. [24] stated that no related mortality was found in
the subgroup of selected PA patients without an ileostomy
(n = 15). Moreover, they reported overall morbidity and seri-
ous complication rates to be lower in PA patients without a
stoma (respectively, 0% vs. 27%, p = 0.01, and 23% vs. 67%,
p = 0.042). In the Ladies trial [25], PA patients with (n = 40)
and without (n = 17) an ileostomy were compared. No differ-
ences in overall morbidity (4/17 (23.5%) vs. 18/40 (45%), p =
0.15) and mortality (0 vs. 3/40 (7.5%), p = 0.55) were found,
but patients without an ileostomy had a significantly shorter
median postoperative stay (7 (11–14) days vs. 11 (7–14), p =
0.01). In their overall cohort (including Hinchey I/II divertic-
ulitis), Vermeulen and colleagues [30] found no difference in
complication rates between PA patients with or without an
ileostomy (respectively, 19% vs. 11%, p = 0.42).
Patient-reported outcomes
Patient-reported outcomes were only identified within the
Ladies trial [25]. During the 12-month follow-up period, ques-
tionnaires to measure health-related quality of life were sent
out at weeks 2 and 4, and months 3, 6, and 12 after the initial
procedure. The questionnaires used were the EuroQol-5D-3-
level, Short Form-36v2, and Gastrointestinal Quality of Life
Index. Between treatment groups, no significant differences
were found in summarized scores or subscales.
Cost-related outcomes
Two studies compared both procedures in terms of associated
costs. Schilling et al. [28] compared costs (converted to US
dollars) associated with operative time, intensive care and
hospital stay, and other resources (e.g., antibiotics, packed
Int J Colorectal Dis
red blood cells, and fresh frozen plasma), demonstrating over-
all expenses to be 74 to 299% higher for HP with subsequent
restoration of intestinal continuity as compared to PA.
Oberkofler et al. [23] reported on in-hospital costs in US dol-
lars, but found no significant differences for the index and
reversal procedure or both procedures combined. Mean (s.d.)
costs associated with the combined procedures were 77.943 ±
50.352 and 75.208 ± 58.002 (p = 0.880) for HP and PA, re-
spectively. A cost analysis of the DIVA arm of the Ladies trial
is to be expected [25].
Discussion
From this systematic review and meta-analysis of the avail-
able evidence on PA versus HP for perforated diverticulitis
with purulent or fecal peritonitis, several arguments can be
identified to support the choice of PA over HP. Firstly, no
difference inmortality andmorbidity after the index procedure
was found between both procedures. Secondly, PA patients
were more likely to have their stoma reversed and to be stoma
free during follow-up, as compared to HP patients. In addi-
tion, the occurrence of reversal-related morbidity was less
likely in the PA group.
Although in recent years other meta-analyses on this topic
have been published, the present study included the recently
published Ladies trial [25], which allowed for the analysis of a
larger cohort of patients from randomized studies. Moreover,
as compared to these previous review articles, a more exten-
sive scope of outcomes (e.g., patient-reported and cost-relat-
ed) and results within subgroups of interest (e.g., PA patients
with or without ileostomy and Hinchey IV patients) were
assessed.
The present results are generally in line with those from
previous meta-analyses. With regard to overall mortality from
randomized and observational studies, Gachabayov et al. [34]
and Shaban et al. [35] found PA to be favorable over HP,
which was also the case in the present quantitative analysis
of mortality within the included observational studies.
However, in the subgroup analysis of randomized studies in
a
b
c
Fig. 2 Quantitative analyses of a short-term mortality rates in randomized controlled trials, b long-term mortality rates in randomized controlled trials,
and c overall mortality rates during follow-up in observational studies
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the present study, no difference between treatment groups was
demonstrated, which is comparable to the outcomes found by
Acuna et al. [36]. Furthermore, Acuna et al. [36] and
Gachabayov et al. [34] both demonstrated PA patients to be
more likely to undergo stoma reversal and be stoma free dur-
ing follow-up, which is similar to the present results. Recently,
two population-based analyses of patients who underwent
emergency surgery for acute diverticulitis in the USA were
published by Lee et al. [37] and Gawlick et al. [38].
Although these studies were not included in this meta-
analysis due to the lack of specification on Hinchey grades
of included patients, their outcomes provide context to the
present findings. The authors show favorable outcomes with
regard to mortality after PA as compared to HP and did not
find differences in complication rates. Interestingly, a third US
population-based study by Cauley et al. [39] concluded less
favorable on the role of PA. Most importantly, all three studies
corrected for potential confounders by means of multivariable
regression analyses incorporating factors such as age, BMI,
ASA grade, and severity of sepsis. The importance of these
potential confounders must be emphasized, as treatment out-
comes might be subject to confounding by indication and,
thereby, influence the generalizability and interpretation of
the present results. Notably, from the quantitative synthesis
of baseline characteristics within the included observational
studies, this present study indeed found that PA patients were
more likely to be younger and have less severe disease in
terms of Hinchey grade and MPI scores.
In this review, results were only used for quantitative anal-
yses if they could be assessed specifically for Hinchey III and
IV diverticulitis. This strict inclusion and analysis approach
was chosen in order to strengthen our conclusion, by avoiding
the chance of overestimating true treatment effects through
inclusion of patients with less severe disease entities (e.g.,
Hinchey II diverticulitis). In addition, another strength of this
study is the before-mentioned broad scope of outcomes, in-
cluding cost-related and patient-reported outcomes.
Diverticulitis is a costly disease and the incidence of perforat-
ed diverticulitis is increasing; therefore, insights into the treat-
ment costs are of interest [15, 40, 41]. With benefits such as
higher reversal rates and less reversal-related morbidity, PA
has the potential to save both direct and indirect medical costs.
However, despite its relevance, only two studies reported on
the directly associated costs and, therefore, no robust
a
b
c
Fig. 3 Quantitative analyses of a overall morbidity rates in randomized controlled trials, b short-term serious complications in randomized controlled
trials, and c overall morbidity rates in observational studies
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conclusions could yet be drawn [23, 28], especially, since
cost-effectiveness and cost-utility analyses were not de-
scribed. The presence of a stoma is known to negatively affect
factors such as physical function and body image, and, con-
sequently, quality of life [14]. In this regard, the stoma-related
benefits of PA might be able to improve the overall quality of
life. Nevertheless, patient-related outcomes could only be
identified in the Ladies trial, which showed no differences in
outcomes of general and gastro-intestinal questionnaires [25].
Novel and stronger evidence could be of importance, as the
potential beneficial cost-related and patient-reported outcomes
could likely be valuable additional arguments to opt for PA.
Moreover, it could help with its wider implementation into
clinical practice, particularly, as it is suggested that HP still
remains the most widely used procedure in past years [37].
A lack of evidence was identified with regard to the ques-
tion whether or not it is safe to omit the construction of a
defunctioning ileostomy in PA patients, and, if so, under what
circumstances. Results for PA patients without an ileostomy
seemed comparable to those of patients with an ileostomy,
albeit that groups were small and at risk for selection bias
[25]. Similarly, outcomes specifically reported for Hinchey
IV patients were scarce and consisted of relatively small
groups. It was demonstrated that PA had a significantly better
a
b
c
d
Fig. 4 Quantitative analyses of randomized controlled trials: a reversal rates of constructed stomas, b number of stoma-free patients, c reversal-related
morbidity, d reversal-related serious complications
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12-month stoma-free survival as compared to HP within
Hinchey IV patients [25]. Additionally, some authors found
Hinchey IV to be independently associated with an increased
morbidity risk, whereas others found no differences between
Hinchey III and IV patients [11, 22, 25, 30]. Nevertheless,
despite the absence of results from larger cohorts of Hinchey
IV, the majority of national and international guidelines still
state the choice of PA with proximal diversion as a possible
treatment option for these patients [5].
There are some limitations to the present study that are
important to acknowledge. Most of the included studies
consisted of small patient groups and were prone to selection
bias due to their retrospective design. More importantly, there
was substantial methodological heterogeneity between includ-
ed studies, for both observational and randomized studies. For
instance, differences in intraoperative details, follow-up dura-
tion, and definitions of morbidity were present. In order to
reduce the effect of this heterogeneity, subgroup analyses of
the included RCTs were performed, which for some outcomes
showed differences with outcomes from observational studies.
Nevertheless, even between these trials, several methodolog-
ical differences existed, such as the moment of randomization,
outcome definitions, and follow-up duration.
Interestingly, all four trials were terminated early for rea-
sons of difficulties with patient accrual, which corresponds
with the evidence that trials in the acute care setting are noto-
riously difficult to conduct and more often lead to early dis-
continuation [42]. However, more importantly, it should clear-
ly be noted that these trial populations might still be a selected
patient sample, as the decision to randomize an eligible patient
might have been subject to surgeon’s preference. A compari-
son with eligible non-included patients could have helped ob-
jectify this potential bias and increase external generalizabili-
ty, but was only reported in the Ladies trial. Additionally, the
trial by Oberkofler and colleagues briefly reported on the
numbers of patients that were not screened for eligibility or
were not included after screening, but it did not compare pa-
tient and disease characteristics of these groups with those of
the included patients [23]. Furthermore, high-risk patients
(e.g., hemodynamically unstable or immunocompromised)
were not included or underrepresented in this systematic re-
view. For example, two of the four trials specifically stated
hemodynamic instability to be an exclusion criterion. Hence,
even though the evidence identifies PA to be the preferred
approach to HP, accurate patient selection still remains key.
Indeed, in a recent evidence-based EAES/SAGES consensus
report, it was stated that PAwith proximal diversion should be
considered over HP in the appropriate clinical setting, but that
HP remains the preferred operation for hemodynamically un-
stable patients [43].
To overcome some of the mentioned methodological prob-
lems and to find evidence to fill in the identified gaps in cur-
rent knowledge, future research might benefit from gathering
data in the context of multi-center or (inter)national audit stud-
ies. Through multi-center collaboration and prospective (pref-
erably long term) data collection in a large sample of patients,
such a study design has the ability to provide insights into
current clinical practice and treatment trends, and to analyze
outcomes with adjustment for known confounders, as well as
to assess outcomes in subgroups such as PA patients with or
without ileostomy or Hinchey IV patients. Moreover, the role
of emergency laparoscopic sigmoidectomy could potentially
be further assessed in this context, as recent promising evi-
dence found it to be superior in terms of postoperative mor-
bidity and hospital stay and concluded it to be feasible in
selected patients and performed by experienced hands [32,
44]. The DAMASCUS study, a snapshot collaborative audit
study on treatment of acute diverticulitis, is an example of
such a design and its results are awaited with interest,
https://www.thedukesclub.org.uk/wp-content/uploads/2019/
07/DAMASCUS-Study-Summary.pdf. Lastly, with regard to
rates of stoma reversal, Hartmann’s reversals in particular, it
can be hypothesized that restoration of continuity will take
place either later or not at all in those patients that have an
impaired clinical condition. This is already partly reflected in
the reported reasons for non-reversal within the published tri-
als, but is also of great value to assess within the long-term
follow-up of existing or novel studies.
In conclusion, this updated systematic review and
meta-analysis provides several arguments to prefer PA
over HP for the treatment of perforated diverticulitis
with purulent or fecal peritonitis. Importantly, between-
study heterogeneity needs to be considered while
interpreting the present results and, above all, the find-
ings should be interpreted within the context of hemo-
dynamically stable and immunocompetent patients. In
addition, this study identified gaps in current knowledge
that are of interest for future investigation and of which
results might further aid accurate surgical decision-
making and optimal treatment within the setting of per-
forated diverticulitis.
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